Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 29)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A CYTR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for CYTR 13 $25 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTRX CORP 5 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A CytRx Corp 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala CYTRX CORP (CYTR=US) 2-weeks forecast 1 $10 View Abstract
6-Feb-10 Pechala's Reports Frantisek Pechala CYTRX CORP (CYTR=US) 12-months forecast 1 $15 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CYTRX -- CYTR 1 $4 View Abstract
Next 19

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
25-Jan-10 Griffin Securities, Inc. Keith Markey, Chrystyna Bedrij, Mark Merrill Griffin Securities Updates Coverage on CytRx Corp. (CYTR) 18 $50 View Abstract
8-Jan-10 Roth Capital Partners, Inc. Research Department Morning Call Summary 19 $50 View Abstract
8-Jan-10 Roth Capital Partners, Inc. Edward Nash A Burgeoning Biotech With A Growing Oncology Franchise 21 $75 View Abstract

Independent Reports (Showing 1 to 10 of 26)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A CYTR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for BIOTECHNOLOGY 18 $49 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for CYTR 13 $25 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTRX CORP 5 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A CytRx Corp 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala CYTRX CORP (CYTR=US) 2-weeks forecast 1 $10 View Abstract
6-Feb-10 Pechala's Reports Frantisek Pechala CYTRX CORP (CYTR=US) 12-months forecast 1 $15 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CYTRX -- CYTR 1 $4 View Abstract
Next 16

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.